Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement …

F Brioude, JM Kalish, A Mussa, AC Foster… - Nat Rev …, 2018 - openaccess.sgul.ac.uk
Beckwith-Wiedemann syndrome (BWS), a human genomic imprinting disorder, is
characterized by phenotypic variability that might include overgrowth, macroglossia …

[HTML][HTML] Diagnosis and management of Beckwith-Wiedemann syndrome

KH Wang, J Kupa, KA Duffy, JM Kalish - Frontiers in pediatrics, 2020 - frontiersin.org
Beckwith-Wiedemann syndrome (BWS) is a human genomic imprinting disorder that
presents with a wide spectrum of clinical features including overgrowth, abdominal wall …

Imprinting disorders: a group of congenital disorders with overlapping patterns of molecular changes affecting imprinted loci

T Eggermann, G Perez de Nanclares, ER Maher… - Clinical …, 2015 - Springer
Congenital imprinting disorders (IDs) are characterised by molecular changes affecting
imprinted chromosomal regions and genes, ie genes that are expressed in a parent-of-origin …

Cancer risk in Beckwith-Wiedemann syndrome: a systematic review and meta-analysis outlining a novel (Epi) genotype specific histotype targeted screening protocol

A Mussa, C Molinatto, G Baldassarre, E Riberi… - The Journal of …, 2016 - Elsevier
Objective To compare tumor risk in the 4 Beckwith-Wiedemann syndrome (BWS) molecular
subgroups: Imprinting Control Region 1 Gain of Methylation (ICR1-GoM), Imprinting Control …

(Epi) genotype–phenotype correlations in Beckwith–Wiedemann syndrome

A Mussa, S Russo, A De Crescenzo, A Freschi… - European journal of …, 2016 - nature.com
Beckwith–Wiedemann syndrome (BWS) is characterized by cancer predisposition,
overgrowth and highly variable association of macroglossia, abdominal wall defects …

[HTML][HTML] Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement

F Brioude, JM Kalish, A Mussa, AC Foster… - Nature Reviews …, 2018 - nature.com
Abstract Beckwith–Wiedemann syndrome (BWS), a human genomic imprinting disorder, is
characterized by phenotypic variability that might include overgrowth, macroglossia …

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

DR Matthews, Q Li, V Perkovic, KW Mahaffey… - Diabetologia, 2019 - Springer
Aims/hypothesis The primary analysis of the Canagliflozin cardioVascular Assessment
Study (CANVAS) Program showed canagliflozin to have a beneficial effect on …

[PDF][PDF] Epigenetics and imprinting in human disease

JM Kalish, C Jiang, MS Bartolomei - The International journal of …, 2014 - ijdb.ehu.es
Most genes are expressed from both parental chromosomes; however, a small number of
genes in mammals are imprinted and expressed in a parent-of-origin specific manner …

[PDF][PDF] Characterization of prevalence and health consequences of uniparental disomy in four million individuals from the general population

P Nakka, SP Smith, AH O'Donnell-Luria… - The American Journal of …, 2019 - cell.com
Meiotic nondisjunction and resulting aneuploidy can lead to severe health consequences in
humans. Aneuploidy rescue can restore euploidy but may result in uniparental disomy …

First step towards a consensus strategy for multi-locus diagnostic testing of imprinting disorders

D Mackay, J Bliek, M Kagami, J Tenorio-Castano… - Clinical …, 2022 - Springer
Background Imprinting disorders, which affect growth, development, metabolism and
neoplasia risk, are caused by genetic or epigenetic changes to genes that are expressed …